Bioventus Invites Clinicians Attending NASS to Help Raise $10,000 for Research
DURHAM, NC – November 10, 2014 – Bioventus, a global leader in orthobiologic solutions, today announced a program to raise up to $10,000 for research on spine-related disabilities. Bioventus, who recently acquired the OsteoAMP® product line, intellectual property and commercial business from Advanced Biologics, will be exhibiting in booth #419 at the 2014 North American Spine Society (NASS) Annual Meeting. For each clinician member of NASS that visits the Bioventus booth, the company will donate $100 to the NASS Annual Research Fund. Bioventus is attempting to raise $10,000 during the exhibition days (November 13-15) of the annual meeting at the Moscone Center, in San Francisco.
By visiting the booth, clinicians will also learn more about OsteoAMP a tissue based bone biologic product used by spine surgeons to promote natural bone growth and healing. OsteoAMP is a bone allograft made using a proprietary process designed to retain the bone’s natural growth factor complement. It comes in four formats (granules, compressible sponges, putty, and structural grafts) and is a cost-effective alternative to recombinant growth factors and allograft-derived stem cells.
“Spine related disabilities are recognized as the leading cause of suffering worldwide and Bioventus believes products like OsteoAMP can help spine surgeons alleviate this suffering,” said Henry Tung, M.D., Vice President and General Manager of Surgical Orthobiologics of Bioventus. “However, more solutions are needed and that’s why we want to raise money for further research while the leaders in the North American spine community are together during NASS 2014. In addition, we invite clinicians to visit us so we can better understand their challenges and unmet needs.”
About Bioventus
Bioventus LLC is an Orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company’s innovative products include market-leading devices, therapies and diagnostics that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com
Bioventus Announces Divestiture of its Wound Business
May 10, 2023
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
October 14, 2022
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago Full Launch…
Bioventus Completes CartiHeal Acquisition
July 12, 2022
Bioventus Completes CartiHeal Acquisition DURHAM, NC – July 12, 2022 – Bioventus Inc. (Nasdaq:…